Login / Signup

Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study.

María Fernanda Zavala-MirandaAna María Sobrino-VargasAdriana Hernández-AndradeValeria Caballero-MalacaraAbril A Perez-AriasSofía E Márquez-MacedoAlberto Nordmann-GomesValeria Navarro-SánchezBernardo Juárez-CuevasNorma Ofelia Uribe-UribeJuan Manuel Mejía-Vilet
Published in: Clinical rheumatology (2024)
EXO-1/2 is a novel antigen detected in class 5 LN and associated with a good prognosis of kidney function. The incorporation of EXO-1/2 staining in clinical practice can potentially modify the management of LN due to its prognostic implications. Key Points • Exostosin-1/exostosin-2 antigen has been found in cases of membranous nephropathy associated with autoimmune diseases such as systemic lupus erythematosus. • Exostosin-1/exostosin-2 staining in the kidney biopsy of class 5 or mixed class 3/4 + 5 lupus nephritis is associated with a good long-term prognosis of kidney function. • The incorporation of exostosin-1/exostosin-2 staining into clinical practice can potentially modify management due to its prognostic implications.
Keyphrases
  • clinical practice
  • systemic lupus erythematosus
  • poor prognosis
  • flow cytometry
  • binding protein
  • ultrasound guided
  • long non coding rna
  • glycemic control